590 related articles for article (PubMed ID: 20542809)
1. A perlecan-inducing compound significantly inhibits smooth muscle cell function and in-stent intimal hyperplasia: novel insights into the diverse biological effects of perlecan.
Segev A; Nili N; Osherov AB; Qiang B; Wong AJ; Pillarisetti S; Strauss BH
EuroIntervention; 2010 May; 6(1):134-40. PubMed ID: 20542809
[TBL] [Abstract][Full Text] [Related]
2. Effects of cytochalasin D-eluting stents on intimal hyperplasia in a porcine coronary artery model.
Salu KJ; Bosmans JM; Huang Y; Hendriks M; Verhoeven M; Levels A; Cooper S; De Scheerder IK; Vrints CJ; Bult H
Cardiovasc Res; 2006 Feb; 69(2):536-44. PubMed ID: 16386237
[TBL] [Abstract][Full Text] [Related]
3. Arsenic trioxide eluting stent reduces neointima formation in a rabbit iliac artery injury model.
Yang W; Ge J; Liu H; Zhao K; Liu X; Qu X; Li W; Huang Y; Sun A; Zou Y
Cardiovasc Res; 2006 Dec; 72(3):483-93. PubMed ID: 17020754
[TBL] [Abstract][Full Text] [Related]
4. Polymer-free cerivastatin-eluting stent shows superior neointimal inhibition with preserved vasomotor function compared to polymer-based paclitaxel-eluting stent in rabbit iliac arteries.
Pendyala L; Yin X; Li J; Shinke T; Xu Y; Chen JP; King SB; Colley K; Goodchild T; Chronos N; Hou D
EuroIntervention; 2010 May; 6(1):126-33. PubMed ID: 20542808
[TBL] [Abstract][Full Text] [Related]
5. Leukotriene receptor antagonism and the prevention of extracellular matrix degradation during atherosclerosis and in-stent stenosis.
Hlawaty H; Jacob MP; Louedec L; Letourneur D; Brink C; Michel JB; Feldman L; Bäck M
Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):518-24. PubMed ID: 19164806
[TBL] [Abstract][Full Text] [Related]
6. Effects of curcumin for preventing restenosis in a hypercholesterolemic rabbit iliac artery stent model.
Jang HS; Nam HY; Kim JM; Hahm DH; Nam SH; Kim KL; Joo JR; Suh W; Park JS; Kim DK; Gwon HC
Catheter Cardiovasc Interv; 2009 Nov; 74(6):881-8. PubMed ID: 19496118
[TBL] [Abstract][Full Text] [Related]
7. Increased intimal hyperplasia and smooth muscle cell proliferation in transgenic mice with heparan sulfate-deficient perlecan.
Tran PK; Tran-Lundmark K; Soininen R; Tryggvason K; Thyberg J; Hedin U
Circ Res; 2004 Mar; 94(4):550-8. PubMed ID: 14739157
[TBL] [Abstract][Full Text] [Related]
8. The role of perlecan in arterial injury and angiogenesis.
Segev A; Nili N; Strauss BH
Cardiovasc Res; 2004 Sep; 63(4):603-10. PubMed ID: 15306215
[TBL] [Abstract][Full Text] [Related]
9. Reduction of In-Stent Restenosis by Cholesteryl Ester Transfer Protein Inhibition.
Wu BJ; Li Y; Ong KL; Sun Y; Shrestha S; Hou L; Johns D; Barter PJ; Rye KA
Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2333-2341. PubMed ID: 29025709
[TBL] [Abstract][Full Text] [Related]
10. Effects of pentoxifylline on the vascular response to injury after angioplasty in rabbit iliac arteries.
Busk M; Mertz H; Espersen GT; Rasmussen K; Maeng M
Basic Res Cardiol; 2008 May; 103(3):257-64. PubMed ID: 18087666
[TBL] [Abstract][Full Text] [Related]
11. Local cyclin-dependent kinase inhibition by flavopiridol inhibits coronary artery smooth muscle cell proliferation and migration: Implications for the applicability on drug-eluting stents to prevent neointima formation following vascular injury.
Jaschke B; Milz S; Vogeser M; Michaelis C; Vorpahl M; Schömig A; Kastrati A; Wessely R
FASEB J; 2004 Aug; 18(11):1285-7. PubMed ID: 15180955
[TBL] [Abstract][Full Text] [Related]
12. Two-dimensional fluorescence in-gel electrophoresis of coronary restenosis tissues in minipigs: increased adipocyte fatty acid binding protein induces reactive oxygen species-mediated growth and migration in smooth muscle cells.
Lu L; Wang YN; Sun WH; Liu ZH; Zhang Q; Pu LJ; Yang K; Wang LJ; Zhu ZB; Meng H; Yang P; Du R; Chen QJ; Wang LS; Yu H; Shen WF
Arterioscler Thromb Vasc Biol; 2013 Mar; 33(3):572-80. PubMed ID: 23372061
[TBL] [Abstract][Full Text] [Related]
13. A novel drug-eluting stent coated with an integrin-binding cyclic Arg-Gly-Asp peptide inhibits neointimal hyperplasia by recruiting endothelial progenitor cells.
Blindt R; Vogt F; Astafieva I; Fach C; Hristov M; Krott N; Seitz B; Kapurniotu A; Kwok C; Dewor M; Bosserhoff AK; Bernhagen J; Hanrath P; Hoffmann R; Weber C
J Am Coll Cardiol; 2006 May; 47(9):1786-95. PubMed ID: 16682302
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor (VEGF)-eluting stents: in vivo effects on thrombosis, endothelialization and intimal hyperplasia.
Swanson N; Hogrefe K; Javed Q; Malik N; Gershlick AH
J Invasive Cardiol; 2003 Dec; 15(12):688-92. PubMed ID: 14660819
[TBL] [Abstract][Full Text] [Related]
15. Comparative assessment of transient exposure of paclitaxel or zotarolimus on in vitro vascular cell death, proliferation, migration, and proinflammatory biomarker expression.
Steinfeld DS; Liu AP; Hsu SH; Chan YF; Stankus JJ; Pacetti SD; Tai JT
J Cardiovasc Pharmacol; 2012 Aug; 60(2):179-86. PubMed ID: 22561362
[TBL] [Abstract][Full Text] [Related]
16. Comparative characterization of cellular and molecular anti-restenotic profiles of paclitaxel and sirolimus. Implications for local drug delivery.
Wessely R; Blaich B; Belaiba RS; Merl S; Görlach A; Kastrati A; Schömig A
Thromb Haemost; 2007 Jun; 97(6):1003-12. PubMed ID: 17549304
[TBL] [Abstract][Full Text] [Related]
17. Paclitaxel and sirolimus differentially affect growth and motility of endothelial progenitor cells and coronary artery smooth muscle cells.
Clever YP; Cremers B; Krauss B; Böhm M; Speck U; Laufs U; Scheller B
EuroIntervention; 2011 May; 7 Suppl K():K32-42. PubMed ID: 22027725
[TBL] [Abstract][Full Text] [Related]
18. Low molecular weight fucoidan prevents intimal hyperplasia in rat injured thoracic aorta through the modulation of matrix metalloproteinase-2 expression.
Hlawaty H; Suffee N; Sutton A; Oudar O; Haddad O; Ollivier V; Laguillier-Morizot C; Gattegno L; Letourneur D; Charnaux N
Biochem Pharmacol; 2011 Jan; 81(2):233-43. PubMed ID: 20887714
[TBL] [Abstract][Full Text] [Related]
19. Decorin inhibition of PDGF-stimulated vascular smooth muscle cell function: potential mechanism for inhibition of intimal hyperplasia after balloon angioplasty.
Nili N; Cheema AN; Giordano FJ; Barolet AW; Babaei S; Hickey R; Eskandarian MR; Smeets M; Butany J; Pasterkamp G; Strauss BH
Am J Pathol; 2003 Sep; 163(3):869-78. PubMed ID: 12937128
[TBL] [Abstract][Full Text] [Related]
20. Antirestenotic effects of a novel polymer-coated d-24851 eluting stent. Experimental data in a rabbit iliac artery model.
Lysitsas DN; Katsouras CS; Papakostas JC; Toumpoulis IK; Angelidis C; Bozidis P; Thomas CG; Seferiadis K; Psychoyios N; Frillingos S; Pavlidis N; Marinos E; Khaldi L; Sideris DA; Michalis LK
Cardiovasc Intervent Radiol; 2007; 30(6):1192-200. PubMed ID: 17828426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
